Olusola Ajilore MD PhD

Breadcrumb

  1. Profile
  2. Olusola Ajilore

Olusola Ajilore MD PhD

Olusola Ajilore
Designation
  • Associate Head for Faculty Development
  • University of Illinois Center for Depression and Resilience (UI CDR) Professor of Psychiatry
  • Director, Mood and Anxiety Disorders Program
  • Director, Clinical Research Core/Center for Clinical and Translational Science
  • Director, Adult Neuroscience Residency Research Track
  • Co-Director, UICOM Medical Scientist Training Program
  • Department of Psychiatry
  • University of Illinois-Chicago
Contact Information
  • oajilore [at] uic.edu
  • (312) 413-4562
  • College of Medicine, Department of Psychiatry
    University of Illinois Chicago

  • School of Public Health / Psychiatric Institute (SPHPI)
    1601 W. Taylor St.
    SPHPI MC 912
    Chicago IL 60612
  • Room #:586
  • -----------------------------------------------
  • College of Medicine, Department of Psychiatry
    University of Illinois Chicago

  • Neuropsychiatric Institute (NPI)
    912 S. Wood St.
    Department of Psychiatry (MC 913)
    Chicago IL 60612
  • Room #:625

Dr. Ajilore's research goal is to understand the pathophysiology of major depressive disorder in the context of medical co-morbidities and late life using novel magnetic resonance imaging techniques. His group focuses on using structural and functional brain connectivity to study the brain as a network.

Using these modalities, they have developed innovative ways of discovering brain alterations associated with major depression that may lead to patient-specific targets for intervention and treatment.  

  • academic

    Neuroimaging.  Depression and medical co-morbidities.  Late-life depression.  Mood disorders, Geriatric psychiatry.

  • Brain Metabolites in Type 2 Diabetes and Major Depression (funded by NIMH)

  • Jacobs, R.H., Barba, A., Gowins, J.R., Klumpp, H., Jenkins, L., Mickey, B.J., Ajilore O., Pecina, M., Sikora, M., Ryan, K.A., Hsu, D.T., Welsh, R.C., Zubieta, J.K., Phan, K.L., & Langenecker, S.A. (2016). Decoupling of the amygdala to other salience network regions in adolescent onset recurrent major depressive disorder. Psychological Medicine

    Jenkins, L.M., Kassel, M.T., Gabriel, L.B., Gowins, J.R., Hymen, E.A., Verges, A., Calamia, M., Crane, N.A., Jacobs, R.H., Ajilore, O., Welsh, R.C., Drevets, W.C., Phillips, M.L., Zubieta, J-K. & Langenecker, S.A. (in press). Amygdala and dorsomedial hyperactivity to emotional faces in youth with remitted Major Depression. Social Cognitive and Affective Neuroscience

    Rittenhouse CD, Ajilore O, Stickgold, R,  Hobson, JA. State dependent aspects of attention: Differences in reaction times on an exogenous cuing task. Sleep Research 1993 Vol. 22:96-103

    Ajilore O, Stickgold, R, Rittenhouse CD, Hobson, JA. Nightcap: laboratory and home-based evaluation of a portable sleep monitor. Psychophysiology, 1995 Jan, 32(1): 92-8.

    Seidman LJ.,  Kalinowski AG, Kremen WS, Faraone SV, Oscar-Berman M, Ajilore O, Tsuang MT.  Experimental and clinical neuropsychological measures of prefrontal dysfunction in schizophrenia. Neuropsychology, 1995 Oct Vol 9(4) 481-490.

    Seidman LJ, Oscar-Berman M, Kalinowski AG, Ajilore O, Kremen WS, Faraone SV, Tsuang MT, Neuropsychological Measures of Prefrontal Dysfunction in Schizophrenia. Biological Psychiatry, v. 39(#7) pp. 270-270 Apr 1, 1996 .

    Chan, RS, Huey ED, Maecker HL, Cortopassi KM, Howard SA, Iyer AM, McIntosh LJ, Ajilore OA, Brooke SM, Sapolsky RM. Endocrine Modulators of Necrotic Neuron Death. Brain Pathology 1996 Oct; 6(4):481-91.

    Ajilore OA and Sapolsky RM. Application of silicon microphysiometry to tissue slices: Detection of metabolic correlates of selective vulnerability. Brain Research 1997 Mar 28; 752(1-2): 99-106.

    Ajilore OA and Sapolsky RM. In vivo Characterization of 11beta-Hydroxysteroid Dehydrogenase in Rat Hippocampus Using Glucocorticoid Neuroendangerment as an Endpoint. . Neuroendocrinology 1999 Feb; 69(2):138-144.

    Yusim A, Franklin L, Brooke SM, Ajilore OA, Sapolsky RM.  Glucocorticoids exacerbate the deleterious effects of gp120 in hippocampal and cortical explants. J Neurochem 2000 Mar;74(3):1000-7.

    Yusim A, Ajilore OA, Bliss T, Sapolsky RM. Glucocorticoids exacerbate insult-induced declines in metabolism in selectively vulnerable hippocampal cell fields. Brain Res 2000 Jul 7;870(1-2):109-117.

    McLaughlin J, Roozendaal B, Dumas T, Gupta A, Ajilore O, Hsieh J, Ho D, Lawrence M, McGaugh JL, Sapolsky R. Sparing of neuronal function postseizure with gene therapy. .Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12804-9

    Rittenhouse CD, Ajilore O, Stickgold, R,  Hobson, JA. State dependent aspects of attention: Differences in reaction times on an exogenous cuing task. Sleep Research 1993 Vol. 22:96-103

    Ajilore O, Stickgold, R, Rittenhouse CD, Hobson, JA. Nightcap: laboratory and home-based evaluation of a portable sleep monitor. Psychophysiology, 1995 Jan, 32(1): 92-8.

    Seidman LJ.,  Kalinowski AG, Kremen WS, Faraone SV, Oscar-Berman M, Ajilore O, Tsuang MT.  Experimental and clinical neuropsychological measures of prefrontal dysfunction in schizophrenia. Neuropsychology, 1995 Oct Vol 9(4) 481-490.

    Seidman LJ, Oscar-Berman M, Kalinowski AG, Ajilore O, Kremen WS, Faraone SV, Tsuang MT, Neuropsychological Measures of Prefrontal Dysfunction in Schizophrenia. Biological Psychiatry, v. 39(#7) pp. 270-270 Apr 1, 1996 .

    Chan, RS, Huey ED, Maecker HL, Cortopassi KM, Howard SA, Iyer AM, McIntosh LJ, Ajilore OA, Brooke SM, Sapolsky RM. Endocrine Modulators of Necrotic Neuron Death. Brain Pathology 1996 Oct; 6(4):481-91.

    Ajilore OA and Sapolsky RM. Application of silicon microphysiometry to tissue slices: Detection of metabolic correlates of selective vulnerability. Brain Research 1997 Mar 28; 752(1-2): 99-106.

    Ajilore OA and Sapolsky RM. In vivo Characterization of 11beta-Hydroxysteroid Dehydrogenase in Rat Hippocampus Using Glucocorticoid Neuroendangerment as an Endpoint. . Neuroendocrinology 1999 Feb; 69(2):138-144.

    Yusim A, Franklin L, Brooke SM, Ajilore OA, Sapolsky RM.  Glucocorticoids exacerbate the deleterious effects of gp120 in hippocampal and cortical explants. J Neurochem 2000 Mar;74(3):1000-7.

    Yusim A, Ajilore OA, Bliss T, Sapolsky RM. Glucocorticoids exacerbate insult-induced declines in metabolism in selectively vulnerable hippocampal cell fields. Brain Res 2000 Jul 7;870(1-2):109-117.

    McLaughlin J, Roozendaal B, Dumas T, Gupta A, Ajilore O, Hsieh J, Ho D, Lawrence M, McGaugh JL, Sapolsky R.Sparing of neuronal function postseizure with gene therapy. .Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12804-9.

    Ajilore OA, Haroon E, Kumaran S, Darwin C, Binesh N,  Mintz J, Miller J,  Thomas MA, Kumar A. Measurement of brain metabolites in patients with type 2 diabetes and major depression using proton magnetic resonance spectroscopy. Neurospychopharmacology. 2007 Jun;32(6):1224-31.

    Watari K, Elderkin-Thompson V, Ajilore O, Haroon E, Darwin C, Pham D, Kumar A.. Neuroanatomical correlates of executive functioning in depressed adults with type 2 diabetes. J Clin Exp Neuropsychol. 2007 Aug 3;:1-9.

    Kumar A, Ajilore O, Kepe V, Barrio JR, Small G. Mood, cognition and in vivo protein imaging: the emerging nexus in clinical neuroscience. Int J Geriatr Psychiatry. 2007 Nov 29.

    Kumar A, Haroon E, Darwin C, Pham D, Ajilore O, Rodriguez G, Mintz J.
    Gray matter prefrontal changes in type 2 diabetes detected using MRI. J Magn Reson Imaging. 2008 Jan;27(1):14-9.

    Watari K, Elderkin-Thompson V, Ajilore O, Haroon E, Darwin C, Pham D, Kumar A. Neuroanatomical correlates of executive functioning in depressed adults with type 2 diabetes. J Clin Exp Neuropsychol. 2008 May;30(4):389-97.

    Kumar A, Ajilore O.Neuroimaging and geriatric psychiatry: the story of an interdisciplinary science and mental illness in the elderly. Am J Geriatr Psychiatry. 2009 Jan;17(1):1-3

    Haroon E, Watari K, Thomas A, Ajilore O, Mintz J, Elderkin-Thompson V, Darwin C, Kumaran S, Kumar A.Prefrontal myo-inositol concentration and visuospatial functioning among diabetic depressed patients. Psychiatry Res. 2009 Jan 30;171(1):10-9.

    Kumar A, Gupta R, Thomas A, Ajilore O, Hellemann G.Focal subcortical biophysical abnormalities in patients diagnosed with type 2 diabetes and depression. Arch Gen Psychiatry. 2009 Mar;66(3):324-30

    Evidence of Early Retinal Microvascular Changes in Patients With Type 2 Diabetes and Depression. Nguyen TT, Wong TY, Islam FM, Hubbard L, Ajilore O, Haroon E, Darwin C, Esser B, Kumar A. Psychosom Med. 2010 Apr 5

    Ajilore OA, Narr KL, Rosenthal J, Pham D, Hamilton L, Watari K, Elderkin-Thompson V, Darwin C, Toga A, Kumar, A. Regional Cortical Gray Matter Thickness Differences Associated with Type 2 Diabetes and Major Depression. Psy Res: Neuroimaging 2010 Sept 8

  • the CoNECt lab

    The Collaborative Neuroimaging Environment for Connectomics at the University of Illinois Chicago (CoNECt@UIC) is an interdisciplinary team of researchers and clinicians devoted to improving our understanding of brain connectivity using novel techniques from neuroimaging and computational neuroscience. We apply these innovative brain mapping methods to elucidate network-based mechanisms associated with a wide variety of clinical conditions and develop new technology-based treatments to address these mechanisms.

Title Description Investigator(s) Category Status
BiAffect the CoNECt lab On-going
Connectome Visualization the CoNECt lab On-going
Connectomics of Mood Disorders the CoNECt lab On-going
DiaBetty the CoNECt lab On-going
Machine Learning-Deep Learning the CoNECt lab On-going
Neuromodulation the CoNECt lab On-going
Virtual Reality the CoNECt lab On-going

*System-generated list from psychiatry research website.

Date Released Title Source
07/07/2023 AI voice coach shows promise in psychotherapy for depression and anxiety
03/28/2023 Dr. Olu Ajilore has been appointed to serve as member for the National Advisory Mental Health Council. National Institute of Mental Health (NIMH)
11/22/2021 Dr. Olu Ajilore was invited to give the Inaugural Harding Endowed Lecture at Ohio State University on October 27th.
05/26/2021 Congratulations Dr. Ajilore for receiving the COM 2021 Faculty of the Year Award! UIC College of Medicine Faculty Awards
03/15/2021 Dr. Olu Ajilore was invited to present work from the CoNeCT lab at the UCLA Brain Mapping Center
03/15/2021 Dr. Olu Ajilore has the following new administrative roles
03/15/2021 Announcing A New Departmental Faculty Mentorship Program
02/12/2020 Dr. Olu Ajilore - UI CDR Professor of Psychiatry
12/12/2019 Dr. Olusola Ajilore was interviewed by the Chicago Tribune Chicago Tribune
09/24/2019 A Fitbit For Your Brain? UIC Psych Lab Develops Free Artificial Intelligence Apps To Help Address Mental Health Crisis Block Club Chicago
08/26/2019 Dr. Olu Ajilore is interviewed about Digital Mental Health for Comcast Newsmakers UI Center on Depression & Resilience
04/02/2019 ‘Rewiring’ your brain is an effective way to combat stress: Some helpful tips Chicago Sun Times
01/15/2019 Dr. Olusola Ajilore interviewed by Healio, "Smartphone app may help people with mood disorders" Healio
01/09/2019 Dr. Olusola Ajilore speaking about BiAffect on WBEZ’s ‘Morning Shift’ WBEZ
10/11/2018 Can Typos Give Insight Into Your Mental Health? The Wall Streeet Journal
09/27/2017 Does Amazon Alexa have a future in diabetes management support? MidCity News